Citius Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CTXR and other ETFs, options, and stocks.About CTXR
Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus on oncology, anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. Its products include I/ONTAK, Mino-Lok, Halo-Lido, Mino-Wrap, and Novecite.
CTXR Key Statistics
Stock Snapshot
The current Citius Pharmaceuticals(CTXR) stock price is $0.61, with a market capitalization of 16.86M. The stock trades at a price-to-earnings (P/E) ratio of -0.24.
As of 2026-07-01, Citius Pharmaceuticals(CTXR) stock has fluctuated between $0.55 and $0.63. The current price stands at $0.61, placing the stock +10.3% above today's low and -2.6% off the high.
The Citius Pharmaceuticals(CTXR)'s current trading volume is 357.34K, compared to an average daily volume of 219.84K.
In the last year, Citius Pharmaceuticals(CTXR) shares hit a 52-week high of $2.48 and a 52-week low of $0.48.
In the last year, Citius Pharmaceuticals(CTXR) shares hit a 52-week high of $2.48 and a 52-week low of $0.48.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.